Startup based in the United States, most recent round Series A, 3 tracked investors.
Based in the United States, Axonis is a startup founded in 2021. Its most recent tracked round is Series A. Brouky records 3 investors associated with the company.
Axonis is a neuro-focused biotechnology company developing first-in-class medicines targeting KCC2 to restore functional inhibition in the brain for treating neurological disorders such as epilepsy and pain.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.